glp 1 weight loss clinical trials New oral GLP-1 drug delivers up to 12% in 36 weeks Transforming obesity: The advancement of

Morgan JE

May improve heart health Several GLP-1 medications appear to improve heart health and reduce the risk for cardiovascular events

Early-phase clinical trials including a Phase 2 dose-ranging study published in the New England Journal of Medicine (2023) have demonstrated significant potential for weight reduction and metabolic improvement, generating considerable scientific interest

SL was applied to lettuce seedlings that had been transferred to plastic containers after two days, with foliar sprays of different concentrations (0, 10, and 20 M) administered three times at 5-day intervals

Pfau ML, Russo SJ